Maternal Serum Pentraxin 3 in Early Pregnancy to Predict Gestational Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

824

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

December 1, 2015

Study Completion Date

December 1, 2015

Conditions
Pregnancy Complications Affecting Fetus (Diagnosis)
Interventions
DIAGNOSTIC_TEST

75gOGTT

oral glucose tolerance test (OGTT) was conducted on all participants between the 24th and 28th gestation weeks.The diagnosis of GDM is made when any of the following plasma glucose values are met or exceeded: FPG≥5.1 mmol/L and/or 1h-PG ≥10.0 mmol/L and/or 2h-PG ≥8.5 mmol/ L.

All Listed Sponsors
lead

Shanghai First Maternity and Infant Hospital

OTHER

NCT03563638 - Maternal Serum Pentraxin 3 in Early Pregnancy to Predict Gestational Diabetes Mellitus | Biotech Hunter | Biotech Hunter